As political pressure mounts over drug prices, Aetna (AET) has disclosed plans to pass along some rebates that the big insurer receives from drug makers, a move that comes less than a month after UnitedHealthcare (UNHcommitted to taking the same step. Starting next year, Aetna will redirect a majority of rebates for around 3 million people.

“We have always believed that consumers should benefit from discounts and rebates that we negotiate with drug manufacturers,” Aetna chief executive Mark Bertolini said in a statement. “Going forward, we hope this additional transparency will encourage these companies to rationalize their pricing and end the practice of annual double-digit price increases.” Unlike UnitedHealthcare, Aetna already offers self-insured employers the option to pass on rebates at the point of sale and will continue to do so, a spokesman explained.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy